Theranexus (XPAR:ALTHX) Interest Expense : €-0.08 Mil (TTM As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Theranexus Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Theranexus's interest expense for the six months ended in Dec. 2023 was € -0.04 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.08 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Theranexus's Operating Income for the six months ended in Dec. 2023 was € -3.74 Mil. Theranexus's Interest Expense for the six months ended in Dec. 2023 was € -0.04 Mil. Theranexus did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Theranexus Interest Expense Historical Data

The historical data trend for Theranexus's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theranexus Interest Expense Chart

Theranexus Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.10

-0.11

-0.03

-0.09

-0.08

Theranexus Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial												-	-0.06	-0.02	-0.05	-0.04

Theranexus Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.08 Mil.

Theranexus (XPAR:ALTHX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Theranexus's Interest Expense for the six months ended in Dec. 2023 was €-0.04 Mil. Its Operating Income for the six months ended in Dec. 2023 was €-3.74 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was €3.64 Mil.

Theranexus's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Theranexus did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Theranexus (XPAR:ALTHX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theranexus SA (XPAR:ALTHX) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

3VG:Germany

Address

60 avenue Rockefeller, Pepiniere Laennec, Lyon, FRA, 69008

Website

https://www.theranexus.com

Theranexus SA is a France based biopharmaceutical company. It is engaged in developing drug candidates to be used in the treatment of central nervous system (CNS) disorders. The company's therapeutics platform is based on simultaneously targeting neurons and glial cells by creating and developing innovative combinations of two distinct drugs: a CNS drug targeting neuronal activity; and a drug targeting glial cells. The drug candidates of the organization are THN102 to treat excessive daytime sleepiness in Parkinson's disease, THN201 for the treatment of neurocognitive disorders in Alzheimer's disease and THN101 for neuropathic pain.

Theranexus (XPAR:ALTHX) Headlines

No Headlines